Agenda
8.30
Registration and coffee
CDM CHALLENGES AND OPPORTUNITIES
9.00
Chairmans opening remarks
Associate Professor Gawaine Powell-Davies, Chief Executive Officer, UNSW Research Center for Primary Health Care & Equity
Associate Professor Gawaine Powell-Davies, Chief Executive Officer, UNSW Research Center for Primary Health Care & Equity
9.10
KEYNOTE INTERNATIONAL ADDRESS |
Chronic Disease
Management in a globalised world
- Trends in chronic disease growth and expenditure
9.50
KEYNOTE ADDRESS |
Chronic care costs in Australia: new
insights on the relationships of adverse events, co
morbidity and preventable hospitalisation that should
shape future payment reforms
Dr. Paul Gross, Health Economist, Director, Institute of Health Economics & Technology Assessment
- Chronic conditions, risk factors and care gaps: what we know
- Data limitations, data linkage and privacy: what we do not know
- Four linked policy concerns: adverse events, preventable admissions, co morbidity and efficient provider payment systems
- Some really expensive chronic conditions: new data on total direct costs of their care and likely growth patterns
- Alternative payment systems that might improve patient satisfaction, provider satisfaction and efficiency
- Reassessing the four Ps: primary care, prevention, population health management and the patient role
Dr. Paul Gross, Health Economist, Director, Institute of Health Economics & Technology Assessment
10.30
Refreshments and networking break
11.00
The business case for investing in workforce CDM
Dr. John Lang, President HAPIA, Managing Director, Good Health Solutions
- Cost effective solutions for employers
- Scope for potential improvements in productivity
- Measuring absenteeism and presenteeism
Dr. John Lang, President HAPIA, Managing Director, Good Health Solutions
11.40
Managing chronic health conditions
Janette Gale, Director, Health Coaching Australia
- Integrating health coaching into organisational systems
Janette Gale, Director, Health Coaching Australia
12.10
Lunch
TOWARDS NATIONAL COORDINATION OF CDM INITIATIVES
1.10
CDM EXPERT PANEL SESSION |
Towards better
coordination of CDM initiatives
Moderator:
Richard Royle, Vice President APHA and Chief Executive Officer, UnitingCare Health
Dr. Stan Goldstein, Senior Medical Advisor, BUPA Australia Group
Dr. Gary Deed, President, Diabetes Australia
Liesel Wett, Acting Chief Executive Officer, Australian General Practice Network
- Managing a multi-provider environment
- The role for Super Clinics in CDM
- The National Primary Health Care Partnership and CDM
- Towards centralisation and coordination of CDM providers: addressing conflicting drivers
- Taking a unified approach: forming partnerships and alliances
- Facilitating collaborative involvement
Moderator:
Richard Royle, Vice President APHA and Chief Executive Officer, UnitingCare Health
Dr. Stan Goldstein, Senior Medical Advisor, BUPA Australia Group
Dr. Gary Deed, President, Diabetes Australia
Liesel Wett, Acting Chief Executive Officer, Australian General Practice Network
2.20
CASE STUDY |
The Team Care Coordination program in
Queensland
Abbe Anderson, Chief Executive Officer, GPpartners
- Outcomes so far
Abbe Anderson, Chief Executive Officer, GPpartners
2.50
Refreshments and networking break
FUNDING CDM PROGRAMS
3.10
PANEL DISCUSSION |
In search of an efficient CDM
financing model
Professor Stephen Leeder, Director, Australian Health Policy Institute
Dr. Andrew Boyden, National Director-Clinical Issues, National Heart Foundation
Liesel Wett, Acting Chief Executive Officer, Australian General Practice Network
Mary Foley, National Health Practice Leader, PricewaterhouseCoopers
- Allowing the funding model to engage seamlessly across the continuum of care
- Measuring economic outcomes beyond healthcare: aligning reimbursement models and reviewing government funding programs to improve outcomes access, effectiveness - and efficiency
- Assessing the possible impact of economic incentives and self management on quality and cost of CDM
- Implications for Medicare and Private Health Insurance
Professor Stephen Leeder, Director, Australian Health Policy Institute
Dr. Andrew Boyden, National Director-Clinical Issues, National Heart Foundation
Liesel Wett, Acting Chief Executive Officer, Australian General Practice Network
Mary Foley, National Health Practice Leader, PricewaterhouseCoopers
MEASURING THE VALUE OF CDM PROGRAMS
4.10
CASE STUDY |
Measurement and evaluation of Chronic
Disease Management Progra
Julie Andrews, Group Manager Health Services, Medibank Private
- Designing and implementing an evaluation approach for chronic disease programs
- Critically analysing the validity of outcomes reports
- Practical guidelines to measuring CDM ROIs
- Accurately measuring the economic value of CDM investments
Julie Andrews, Group Manager Health Services, Medibank Private
4.40
Closing remarks from the Chair
8.45
Registration and coffee
9.00
Welcome from the Chair
DRIVING INNOVATION IN CDM
9.10
Embracing opportunities for private providers
Mark Fitzgibbon, Chief Executive Officer, NIB Health Funds
- Improving capacity and operations to provide quality care
- Meeting financial and performance targets
- Looking ahead as to how the industry will meet the CDM challenge
Mark Fitzgibbon, Chief Executive Officer, NIB Health Funds
9.45
Health Fund's Perspective on CDM
Terry Smith, Chief Executive Officer, HCF of Australia
Terry Smith, Chief Executive Officer, HCF of Australia
10.20
Refreshments and networking break
10.50
The future of CDM in Australia
Dr. Andrew Wilson, Co-President, McKesson Asia-Pacific
- Challenges in todays market
- Market opportunities for service providers
- International market opportunities
Dr. Andrew Wilson, Co-President, McKesson Asia-Pacific
11.30
Achieving solutions that deliver cost effective outcomes
Louise Stewart, Managing Director, Revive Group
- Evaluating outcomes: what has been done and what can be achieved
- Case studies from Australia and overseas
Louise Stewart, Managing Director, Revive Group
12.10
Lunch
PHARMACEUTICALS
1.20
Implementing strategies to increase compliance
Professor Carol Armour, Acting Pro-Vice Chancellor (Research), University of Sydney
- Examining the progress of existing Quality Use of Medicines Programs
- Successfully incorporating compliance drivers into CDM
- Involving the pharmacists in monitoring compliance
- Impact on healthcare costs
Professor Carol Armour, Acting Pro-Vice Chancellor (Research), University of Sydney
LEVERING TECHNOLOGY TO INCREASE THE IMPACT OF CDM
2.00
IT infrastructures, electronic health records and CDM
Roger Glenny, General Manager, National e-Health Transition Authority
- Towards better sharing arrangements and standards
- Using IT to integrate care for chronic conditions and improve clinical outcomes
- Challenges that need to be addressed
Roger Glenny, General Manager, National e-Health Transition Authority
2.30
Microsofts entry in the online health care market
Dr David Dembo, Leader, Health and Human Services, Microsoft Australia
- Extending traditional healthcare services to the home setting
- Capitalising on opportunities using the latest in web communication technologies
- The micro and macro business case
- Operating in different markets
- Potential for Chronic Disease Management programs
Dr David Dembo, Leader, Health and Human Services, Microsoft Australia
3.00
Refreshments and networking break
3.20
Using technology to deliver CDM programs across large
populations including regional and remote areas
Professor Branko Celler, Director, Biomedical Systems Laboratory and Laboratory for Health Telemedics, University of New South Wales
- Experiences so far with remote monitoring
- Training patients to become independent
- Clinical outcomes
Professor Branko Celler, Director, Biomedical Systems Laboratory and Laboratory for Health Telemedics, University of New South Wales
3.50
CASE STUDY |
The implementation of an Intelligent
Disease Management Service
Professor Michael Georgeff, Director e-Health Research, Monash University, Chief Executive Officer, Precedence Healthcare
- Opportunities for telecare monitoring with decision support for chronic disease
- E-Health pilot for Chronic Disease Management
- Using emerging mobile technologies and remote monitors
Professor Michael Georgeff, Director e-Health Research, Monash University, Chief Executive Officer, Precedence Healthcare
4.30
Closing remarks from the Chair
End of the conference
End of the conference
